BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37674493)

  • 1. The 2023 Impact of Inflammatory Bowel Disease in Canada: Direct Health System and Medication Costs.
    Kuenzig ME; Coward S; Targownik LE; Murthy SK; Benchimol EI; Windsor JW; Bernstein CN; Bitton A; Jones JL; Lee K; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Im JHB; Jogendran R; Meka S; Weinstein J; Jones May T; Jogendran M; Tabatabavakili S; Hazan E; Hu M; Osei JA; Khan R; Wang G; Browne M; Davis T; Goddard Q; Gorospe J; Latos K; Mason K; Kerr J; Balche N; Sklar A; Kaplan GG
    J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S23-S34. PubMed ID: 37674493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors.
    Nguyen GC; Targownik LE; Singh H; Benchimol EI; Bitton A; Murthy SK; Bernstein CN; Lee K; Cooke-Lauder J; Kaplan GG
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S68-S72. PubMed ID: 31294386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
    Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.
    Kaplan GG; Bernstein CN; Coward S; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S6-S16. PubMed ID: 31294381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.
    Sin AT; Damman JL; Ziring DA; Gleghorn EE; Garcia-Careaga MG; Gugig RR; Hunter AK; Burgis JC; Bass DM; Park KT
    Inflamm Bowel Dis; 2015 Jun; 21(6):1368-77. PubMed ID: 25839776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
    Park KT; Ehrlich OG; Allen JI; Meadows P; Szigethy EM; Henrichsen K; Kim SC; Lawton RC; Murphy SM; Regueiro M; Rubin DT; Engel-Nitz NM; Heller CA
    Inflamm Bowel Dis; 2020 Jan; 26(1):1-10. PubMed ID: 31112238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel disease: a Canadian burden of illness review.
    Rocchi A; Benchimol EI; Bernstein CN; Bitton A; Feagan B; Panaccione R; Glasgow KW; Fernandes A; Ghosh S
    Can J Gastroenterol; 2012 Nov; 26(11):811-7. PubMed ID: 23166905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Services Utilization, Specialist Care, and Time to Diagnosis with Inflammatory Bowel Disease in Immigrants to Ontario, Canada: A Population-Based Cohort Study.
    Benchimol EI; Manuel DG; Mojaverian N; Mack DR; Nguyen GC; To T; Guttmann A
    Inflamm Bowel Dis; 2016 Oct; 22(10):2482-90. PubMed ID: 27556836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
    Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
    J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2023 Impact of Inflammatory Bowel Disease in Canada: Indirect (Individual and Societal) and Direct Out-of-Pocket Costs.
    Kuenzig ME; Im JHB; Coward S; Windsor JW; Kaplan GG; Murthy SK; Benchimol EI; Bernstein CN; Bitton A; Jones JL; Lee K; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Jones May T; Tabatabavakili S; Jogendran R; Weinstein J; Khan R; Hazan E; Browne M; Davis T; Goddard Q; Gorospe J; Latos K; Mason K; Kerr J; Balche N; Sklar A; Targownik LE
    J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S16-S22. PubMed ID: 37674495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.
    Tan MC; El-Serag HB; Hou JK
    Dig Dis Sci; 2017 Mar; 62(3):607-614. PubMed ID: 28012103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
    Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in the Care of Children with Inflammatory Bowel Disease Within and Across Canadian Provinces: A Multi-Province Population-Based Cohort Study.
    Kuenzig ME; Stukel TA; Carroll MW; Kaplan GG; Otley AR; Singh H; Bitton A; Fung SG; Spruin S; Coward S; Cui Y; Nugent Z; Griffiths AM; Mack DR; Jacobson K; Nguyen GC; Targownik LE; El-Matary W; Bernstein CN; Dummer TJB; Jones JL; Lix LM; Murthy SK; Peña-Sánchez JN; Nasiri S; Benchimol EI;
    Clin Epidemiol; 2024; 16():91-108. PubMed ID: 38374886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental Health Costs of Inflammatory Bowel Diseases.
    Szigethy E; Murphy SM; Ehrlich OG; Engel-Nitz NM; Heller CA; Henrichsen K; Lawton R; Meadows P; Allen JI
    Inflamm Bowel Dis; 2021 Jan; 27(1):40-48. PubMed ID: 32095835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Healthcare Resource Utilization and Costs after the Initiation of Biologic Treatment in Patients with Ulcerative Colitis and Crohn's Disease.
    Perera S; Yang S; Stott-Miller M; Brady J
    J Health Econ Outcomes Res; 2018; 6(1):96-112. PubMed ID: 32685575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of illness analysis of inflammatory bowel disease.
    Pakdin M; Zarei L; Bagheri Lankarani K; Ghahramani S
    BMC Gastroenterol; 2023 Jan; 23(1):21. PubMed ID: 36658489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Sheehan JL; Jacob J; Berinstein EM; Greene-Higgs L; Steiner CA; Berry SK; Shannon C; Cohen-Mekelburg SA; Higgins PDR; Berinstein JA
    Inflamm Bowel Dis; 2022 Dec; 28(12):1904-1914. PubMed ID: 35230420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P068 Racial and Socioeconomic Disparities in Acute Care Utilization in a National Cohort of Veterans With IBD.
    Booth A; Keller E; Forster E; Axon R; Magwood G; Curran T
    Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S18. PubMed ID: 37461985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.